原发性高血压患者激肽释放酶-激肽系统的缺陷以及口服激肽释放酶后的血压降低 - Suppr | 超能文献

Defect in kallikrein-kinin-system in essential hypertension and reduction of blood pressure by orally given kallikrein.

作者信息

Overlack A, Stumpe K O, Zywzock W, Ressel C, Drück F

出版信息

Adv Exp Med Biol. 1979;120B:539-47.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Defect in kallikrein-kinin-system in essential hypertension and reduction of blood pressure by orally given kallikrein.原发性高血压患者激肽释放酶-激肽系统的缺陷以及口服激肽释放酶后的血压降低

Adv Exp Med Biol. 1979;120B:539-47.

2

Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.高血压中的肾激肽释放酶-激肽系统和前列腺素：它们与肾素-血管紧张素-醛固酮系统的关系。

Adv Exp Med Biol. 1979;120B:487-501.

3

Are the changes in urinary kallikrein excretion on altering sodium intake an index of salt sensitivity?改变钠摄入量时尿激肽释放酶排泄量的变化是否为盐敏感性的一个指标？

J Hum Hypertens. 1994 Aug;8(8):619-21.

4

Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.原发性高血压患者口服激肽释放酶后，尿激肽释放酶活性降低及血压升高的情况恢复正常。

Klin Wochenschr. 1980 Jan 2;58(1):37-42. doi: 10.1007/BF01477142.

5

Urinary kallikrein in normal renin essential hypertension.正常肾素型原发性高血压中的尿激肽释放酶

Circulation. 1977 Nov;56(5):856-9. doi: 10.1161/01.cir.56.5.856.

6

The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.

Jpn Circ J. 1979 Dec;43(12):1105-16. doi: 10.1253/jcj.43.1105.

7

[Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].[高血压患者后代中激肽释放酶-激肽系统和肾素-血管紧张素-醛固酮系统的选定成分]

Ann Acad Med Stetin. 1996;42:123-38.

8

[Studies on kallikrein-kinin system in essential hypertension: urinary kallikrein-kinin system and renin-angiotensin-aldosterone system (author's transl)].原发性高血压中激肽释放酶-激肽系统的研究：尿激肽释放酶-激肽系统与肾素-血管紧张素-醛固酮系统（作者译）

Nihon Naika Gakkai Zasshi. 1978 May 10;67(5):483-94. doi: 10.2169/naika.67.483.

9

Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.硝苯地平在原发性高血压中的降压和利钠作用。肾激肽释放酶-激肽-前列腺素系统及肾素-血管紧张素-醛固酮系统的作用

J Clin Hypertens. 1986 Sep;2(3):263-70.

10

Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.高血压患者的尿激肽释放酶排泄。与钠摄入量和保钠类固醇的关系。

Circ Res. 1974 Dec;35(6):820-5. doi: 10.1161/01.res.35.6.820.

引用本文的文献

1

The kallikrein-kinin system in circulatory and metabolic homeostasis.循环和代谢稳态中的激肽释放酶-激肽系统。

World J Surg. 1981 Jul;5(4):639-51. doi: 10.1007/BF01655022.